Characterization of a human keratinocyte HaCaT cell line model to study the regulation of CYP2S1

Drug Metabolism and Disposition

Volumn 40, Issue 2, 2012, Pages 283-289

  McNeilly, Alison D ^a   Woods, Julie A ^a   Ibbotson, Sally H ^a   Wolf, C Roland ^a   Smith, Gillian ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CYP2S1 PROTEIN; CYTOCHROME P450; CYTOCHROME P450 REDUCTASE; ISOTRETINOIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME SPECIFICITY; GENE EXPRESSION; HACAT CELL; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRAVIOLET RADIATION;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CELL LINE; CHO CELLS; CRICETINAE; CYTOCHROME P-450 ENZYME SYSTEM; DERMATOLOGIC AGENTS; DRUG EVALUATION, PRECLINICAL; ENZYME INDUCTION; HUMANS; KERATINOCYTES; MICROSOMES; NADPH-FERRIHEMOPROTEIN REDUCTASE; OSMOLAR CONCENTRATION; RECOMBINANT PROTEINS; RNA, MESSENGER; TRETINOIN; ULTRAVIOLET RAYS;

ATRA; CRICETULUS GRISEUS;

EID: 84862953352     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.042085     Document Type: Article

References (40)

1. Abu-Abed S, MacLean G, Fraulob V, Chambon P, Petkovich M, and Dollé P (2002) Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis. Mech Dev 110:173-177. (Pubitemid 34020636)
2. Anzenbacher P and Anzenbacherová E (2001) Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 58:737-747. (Pubitemid 32553031)
3. Bui P, Imaizumi S, Beedanagari SR, Reddy ST, and Hankinson O (2011) Human CYP2S1 metabolizes cyclooxygenase- and lipoxygenase-derived eicosanoids. Drug Metab Dispos 39:180-190.
4. Bui PH and Hankinson O (2009) Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli. Mol Pharmacol 76:1031-1043.
5. Bui PH, Hsu EL, and Hankinson O (2009) Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol. Mol Pharmacol 76:1044-1052.
6. Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954.
7. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, and Schenkman JB (2004) Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos 32:840-847. (Pubitemid 38955614)
8. Choudhary D, Jansson I, Sarfarazi M, and Schenkman JB (2006) Physiological significance and expression of P450s in the developing eye. Drug Metab Rev 38:337-352. (Pubitemid 43739013)
9. Delescluse C, Ledirac N, de Sousa G, Pralavorio M, Lesca P and Rahmani R (1998) Cytotoxic effects and induction of cytochromes P450 1A1/2 by insecticides, in hepatic or epidermal cells: binding capability to the Ah receptor. Toxicol Lett 96-97:33-39. (Pubitemid 28430294)
10. Ding S, Yao D, Burchell B, Wolf CR, and Friedberg T (1997) High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation. Arch Biochem Biophys 348:403-410. (Pubitemid 28028493)
11. Downie D, McFadyen MC, Rooney PH, Cruickshank ME, Parkin DE, Miller ID, Telfer C, Melvin WT, and Murray GI (2005) Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res 11:7369-7375. (Pubitemid 41507696)
12. Feng S, Lin L, Wu Q, Zhou W, and Shao C (2006) Study on the expression of RXRalpha in patients with psoriasis vulgaris. Eur J Dermatol 16:33-38. (Pubitemid 43219402)
13. Fiorella PD and Napoli JL (1994) Microsomal retinoic acid metabolism. Effects of cellular retinoic acid-binding protein (type I) and C18-hydroxylation as an initial step. J Biol Chem 269:10538-10544.
14. Goerz G, Barnstorf W, Winnekendonk G, Bolsen K, Fritsch C, Kalka K, and Tsambaos D (1996) Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isoenzymes. Arch Dermatol Res 289:46-51. (Pubitemid 27011067)
15. Gudas LJ (1994) Retinoids and vertebrate development. J Biol Chem 269:15399-15402.
16. Hankinson O (1995) The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307-340.
17. Karlgren M, Miura S, and Ingelman-Sundberg M (2005) Novel extrahepatic cytochrome P450s. Toxicol Appl Pharmacol 207:57-61.
18. Katiyar SK, Matsui MS, and Mukhtar H (2000) Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J Invest Dermatol 114:328-333. (Pubitemid 30417769)
19. Kawai M, Chen J, Cheung CY, and Chang TK (2003) Transcript profiling of cytochrome P450 genes in HL-60 human leukemic cells: upregulation of CYP1B1 by all-trans-retinoic acid. Mol Cell Biochem 248:57-65. (Pubitemid 36833641)
20. Kumarakulasingham M, Rooney PH, Dundas SR, Telfer C, Melvin WT, Curran S, and Murray GI (2005) Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res 11:3758-3765. (Pubitemid 40685593)
21. Leo MA, Lasker JM, Raucy JL, Kim CI, Black M, and Lieber CS (1989) Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch Biochem Biophys 269:305-312. (Pubitemid 19052311)
22. Marek CJ, Tucker SJ, Koruth M, Wallace K, and Wright MC (2007) Expression of CYP2S1 in human hepatic stellate cells. FEBS Lett 581:781-786. (Pubitemid 46216305)
23. Marill J, Cresteil T, Lanotte M, and Chabot GG (2000) Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol 58:1341-1348.
24. Nishida CR, Lee M, and de Montellano PR (2010) Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1. Mol Pharmacol 78:497-502.
25. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
26. Pavek P and Dvorak Z (2008) Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr Drug Metab 9:129-143. (Pubitemid 351461002)
27. Pavez Loriè E, Li H, Vahlquist A, and Törmä H (2009) The involvement of cytochrome p450 (CYP) 26 in the retinoic acid metabolism of human epidermal keratinocytes. Biochim Biophys Acta 1791:220-228.
28. Redfern CP and Todd C (1992) Retinoic acid receptor expression in human skin keratinocytes and dermal fibroblasts in vitro. J Cell Sci 102:113-121.
29. Rivera SP, Saarikoski ST, and Hankinson O (2002) Identification of a novel dioxin-inducible cytochrome P450. Mol Pharmacol 61:255-259. (Pubitemid 34112798)
30. Rivera SP, Wang F, Saarikoski ST, Taylor RT, Chapman B, Zhang R, and Hankinson O (2007) A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia. J Biol Chem 282:10881-10893. (Pubitemid 47100738)
31. Rylander T, Neve EP, Ingelman-Sundberg M, and Oscarson M (2001) Identification and tissue distribution of the novel human cytochrome P450 2S1 (CYP2S1). Biochem Biophys Res Commun 281:529-535. (Pubitemid 32928187)
32. Saarikoski ST, Wikman HA, Smith G, Wolff CH, and Husgafvel-Pursiainen K (2005) Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry. J Histochem Cytochem 53:549-556. (Pubitemid 40593968)
33. Smith G, Dawe RS, Clark C, Evans AT, Comrie MM, Wolf CR, Ferguson J, and Ibbotson SH (2003a) Quantitative real-time reverse transcription-polymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation. J Invest Dermatol 121:390-398. (Pubitemid 36969914)
34. Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, Comrie MM, Ferguson J, and Ibbotson SH (2003b) Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361:1336-1343. (Pubitemid 36514866)
35. Thum T, Erpenbeck VJ, Moeller J, Hohlfeld JM, Krug N, and Borlak J (2006) Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ Health Perspect 114:1655-1661. (Pubitemid 44718269)
36. Traynor NJ, Beattie PE, Ibbotson SH, Moseley H, Ferguson J, and Woods JA (2005) Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. John's Wort supplements and high dose UVA-1 therapy. Toxicol Lett 158:220-224. (Pubitemid 41074818)
37. Villard PH, Sampol E, Elkaim JL, Puyoou F, Casanova D, Sérée E, Durand A, and Lacarelle B (2002) Increase of CYP1B1 transcription in human keratinocytes and HaCaT cells after UV-B exposure. Toxicol Appl Pharmacol 178:137-143. (Pubitemid 34214662)
38. Wang SL, He XY, and Hong JY (2005) Human cytochrome p450 2s1: lack of activity in the metabolic activation of several cigarette smoke carcinogens and in the metabolism of nicotine. Drug Metab Dispos 33:336-340.
39. Wei YD, Rannug U, and Rannug A (1999) UV-induced CYP1A1 gene expression in human cells is mediated by tryptophan. Chem Biol Interact 118:127-140. (Pubitemid 29179538)
40. Wu ZL, Sohl CD, Shimada T, and Guengerich FP (2006) Recombinant enzymes overexpressed in bacteria show broad catalytic specificity of human cytochrome P450 2W1 and limited activity of human cytochrome P450 2S1. Mol Pharmacol 69:2007-2014. (Pubitemid 43894320)